56th EASD Annual Meeting of the European Association for the Study of Diabetes

s Index of Oral Presentations OP 01 Diabetes complications: new insights from cutting edge epidemiologyOP 02 News on the insulin secretion frontOP 03 Insulin sensitivity and biomarkersOP 04 Central actions in diabetesOP 05 Glucose-lowering therapies and the liverOP 06 Uncomplicating the pathogenesis of diabetes complications in humansOP 07 Smoke on the water: Is BAT still hot?OP 08 Charting human beta cell failure in type 1 diabetesOP 09 Novel agents in type 1 diabetesOP 10 Developing better insulinsOP 11 From diagnostics to the end-stage of diabetic kidney diseaseOP 12 NAFLD: Is it all about the liver?OP 13 Diabetic retinopathy: see what's new?OP 14 Taking the long view of diabetesOP 15 Pregnancy in diabetes prediction and outcomesOP 16 Signals and networks in beta cell failureOP 17 Broken heart in diabetesOP 18 Unlocking the potential of digital healthOP 19 Decoding the heritable basis of type 2 diabetesOP 20 Feeding the pipeline: from drugs to surgeryOP 21 SGLT-2 inhibitors: at the heart of the matterOP 22 New Treatments for NAFLD: Hope or Hype?OP 23 Addressing potential new treatments of diabetic kidney diseaseOP 24 Glucagon and hormones beyondOP 25 Incretin based therapiesOP 26 Unusual forms of diabetesOP 27 Macrovascular complications and beyondOP 28 Linking inflammation to metabolismOP 29 What's new in automated insulin deliveryOP 30 Understanding the mechanisms of diabetic kidney diseaseOP 31 Novel aspects of diabetic neuropathyOP 32 Reducing the burden of hypoglycaemiaOP 33 What exercise doesOP 34 Back to the future: risk markers in diabetesOP 35 Diet: not only quantity mattersOP 36 On the road to human islet failure in type 2 diabetesOP 37 A deep dive into the mechanisms of diabetesOP 38 Triggers and drivers of beta cell failure in type 1 diabetesOP 39 Gastro-entero pancreatic factors: organoids, mice and menOP 40 New aspects of novel therapiesOP 41 Fatty mattersOP 42 Diabetes care is expensiveOP 43 Developing beta cellsOP 44 Modelling metabolism: lessons from animalsOP 45 Diabetic foot: new developments in wound healingOP 46 Challenges in delivering diabetes care: new solutionsOP 47 Thinking about diabetes complications in the brainOP 48 Insulin secretion in various subgroups Index of Poster Sessions PS 01 Diabetes and early deathPS 02 Living with chronic diabetes complicationsPS 03 Micro- and macrovascular complications of diabetesPS 04 Global view on diabetes complicationsPS 05 Type 2 diabetes treatment IRLPS 06 Unusual forms of diabetesPS 07 Molecular insights into glucose abnormalitiesPS 08 Pathophysiology of glucose homeostasisPS 09 The inner workings of the pancreasPS 10 Islets and antibodies in type 1 diabetesPS 11 Markers and phenotypes of glucose traitsPS 12 Global aspects on the epidemiology of type 2 diabetesPS 13 Risk factors for type 2 diabetesPS 14 Prevalence of type 2 diabetes around the worldPS 15 Risk factors in type 1 diabetesPS 16 Islet transplants revisitedPS 17 Islets in type 1 diabetes: new playersPS 18 Beta cells under stressPS 19 To live and let die: a beta cell perspectivePS 20 Job description: insulin secretionPS 21 Further down the road to human islet failure in type 2 diabetesPS 22 Sitting and exercising does it allPS 23 The ins and outs of carbohydrate metabolismPS 24 Pregnancy: in vitro and in vivo studiesPS 25 Pregnancy: EpidemiologyPS 26 Pregnancy: Who is at risk?PS 27 Incremental studies on gut hormonesPS 28 The fundamentals of insulin resistancePS 29 Studies on insulin resistancePS 30 Treatment of hyperglycaemia in pregnancyPS 31 Pancreatic hormonesPS 32 Insulin secretion in mice and menPS 33 Something more about obesityPS 34 More about metabolismPS 35 Inflammation in type 2 diabetesPS 36 Models of prediabetes and diabetesPS 37 Models of obesity and insulin resistancePS 38 Lipid metabolismPS 39 Adipokine signallingPS 40 Drugs and environment in obesityPS 41 Weight loss interventionsPS 42 Brain mattersPS 43 SGLT-2 inhibitors: clinical aspectsPS 44 Different aspects of SGLT-2 inhibitorsPS 45 Basic aspects of incretin-based therapiesPS 46 Clinical outcome of incretin-based therapiesPS 47 Glycaemic control and incretin-based therapiesPS 48 Various clinical aspects of incretin-based therapiesPS 49 Various aspects of nutrition and dietPS 50 Oral therapies: metformin, sensitizers and other non-secretagoguesPS 51 Novel agents to treat diabetes and its consequencesPS 52 Novel glucose-lowering agents in type 2 diabetesPS 53 Key issues in improving outcomes in people with diabetes, education and costsPS 54 How to improve diabetes carePS 55 The impact of new basal insulinsPS 56 Insulin therapy: real world studiesPS 57 Insulin therapy: fast acting insulin analoguesPS 58 The challenges of insulin therapy in type 2 diabetesPS 59 Different aspects of insulin therapyPS 60 The continued advance of continuous glucose monitoringPS 61 Insulin pump therapyPS 62 Automated insulin deliveryPS 63 The varied use of technologies in type 2 diabetesPS 64 Novel applications of technology in diabetesPS 65 Novel therapies to reduce hypoglycaemiaPS 66 Mechanisms and clinical consequences of hypoglycaemia in diabetesPS 67 Emerging topics in hypoglycaemiaPS 68 Investigating diabetes distress and depressionPS 69 Aspects of quality of life and well beingPS 70 Digital health in type 2 diabetesPS 71 Is telehealth the answer to improving care in diabetes?PS 72 Predicting prognosis of diabetic kidney diseasePS 73 Clinical aspects of diabetic kidney diseasePS 74 The ROCK and role of experimental kidney diseasePS 75 New tools to view diabetic retinopathyPS 76 Diabetic retinopathy: screening and interventionPS 77 Focus on diabetic foot ulcersPS 78 Hypertension and vascular diseasePS 79 Cure the pain of diabetic neuropathyPS 80 Understanding clinical neuropathyPS 81 From artificial intelligence to treatment of diabetic footPS 82 From biomarkers to genetics of diabetic kidney diseasePS 83 Treatment of NAFLD and diabetes: from food to pharmacologyPS 84 Mechanisms and prevalence of NAFLDPS 85 Lipids everywhere: lipid metabolism in the liver and the heartPS 86 All about coronary arteries and diabetesPS 87 Lipids and glucose: not so good for the heartPS 88 Cardiac complications: of mice, rats and cellsPS 89 Atherosclerotic complications: stemming from cells to the kidneyPS 90 Stiff arteries and how to avoid themPS 91 Cardiac function and dysfunctionPS 92 Cardiovascular complications in humans through and throughPS 93 Diabetes and neoplasiaPS 94 Contemplating cognitive dysfunction in diabetesPS 95 Endothelial cell, circulation and the heartPS 96 Tradition? No! Non-traditional complications of diabetes